A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus. (2013)
Attributed to:
Biomedical Catalyst – Antibody Directed Phototherapy for Oesophageal Adenocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10103-012-1132-1
PubMed Identifier: 22699800
Publication URI: http://europepmc.org/abstract/MED/22699800
Type: Journal Article/Review
Volume: 28
Parent Publication: Lasers in medical science
Issue: 3
ISSN: 0268-8921